Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

Presentation TCT 2022

Case 2: COVID Patient With Clot in Transit

Presenter: Matthew Finn

September 18, 2022

Presentation TCT 2022

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Presenter: Felix Mahfoud

September 17, 2022

Presentation TCT 2022

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Presenter: David Kandzari

September 17, 2022

Presentation TCT 2022

Novel Approaches to Assess Hypertension Control Outside the Office

Presenter: Naomi Fisher

September 17, 2022

Presentation TCT 2022

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Presenter: Melvin Lobo

September 17, 2022

Presentation TCT 2022

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Presenter: Debbie Cohen

September 17, 2022

Presentation Fellows 2021

Lessons Learned from a Career in Interventional Discovery

Presenter: Martin B. Leon

May 08, 2021

Presentation TCT 2016

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Presenter: Emerson C. Perin, Bernard J. Gersh

October 31, 2016

Presentation TCT 2016

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Presenter: Emerson C. Perin, Mariann Gyöngyösi

October 31, 2016

Presentation TCT 2016

Beyond Cells: Cardiac Gene Therapy In Perspective

Presenter: Emerson C. Perin, Marc S. Penn

October 31, 2016

Presentation TCT 2016

New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity

Presenter: Emerson C. Perin, Jozef Bartunek

October 31, 2016

Presentation TCT 2016

Cells Alone Work: Lessons From Recent Clinical Trials

Presenter: Emerson C. Perin

October 31, 2016

Presentation TCT 2016

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

Presenter: Timothy D. Henry, Amit N. Patel, Doris A. Taylor

October 31, 2016

Presentation TCT 2016

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Presenter: Timothy D. Henry, Amit N. Patel

October 31, 2016

Presentation TCT 2016

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Presenter: Timothy D. Henry, Amit N. Patel, Steven A.J. Chamuleau

October 31, 2016

Presentation TCT 2016

Obstacles for Clinical Research: Perspectives From Industry

Presenter: Emerson C. Perin, Ricardo Sanz-Ruiz, Warren Sherman

October 31, 2016

Presentation TCT 2016

Obstacles for Clinical Research: The BAMI Experience

Presenter: Emerson C. Perin, Ricardo Sanz-Ruiz

October 31, 2016

Presentation TCT 2016

Regenerative Products In Perspective: Do They Really Work? Are They Enough?

Presenter: Emerson C. Perin, Ricardo Sanz-Ruiz, Jens Kastrup

October 31, 2016

Advertisement

Case 2: COVID Patient With Clot in Transit

Novel Devices to Treat Hypertension: What Else Should We Expect in the Near Future?

Update on the RADIANCE Clinical Trials Program (Ultra-Sound Renal Denervation)

Update on the SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation)

Novel Approaches to Assess Hypertension Control Outside the Office

Combination Therapy and Patient Outreach to Improve Adherence to Pharmacotherapies

Dietary and Lifestyle Approaches to Hypertension Management: What’s New and What’s Changed

Lessons Learned from a Career in Interventional Discovery

Improving Clinical Science: Priorities and Methods of Clinical Trials in Cardiovascular Regenerative Medicine

Cells at the Moment of Truth: Findings From Meta-analysis and Systematic Reviews

Beyond Cells: Cardiac Gene Therapy In Perspective

New Sights from CHART -1 at 1 Year: Relationship of outcomes to baseline biomarkers and treatment intensity

Cells Alone Work: Lessons From Recent Clinical Trials

When Everything Has Disappeared: Role of Cell-Based Engineered Tissue and Organ Transplantation.

When Cells are Not Enough: Role of Cellular and Non-Cellular Injectable Biomaterials

Improving Translational Science In Cardiac Regenerative Medicine. Utility of Animal Models

Obstacles for Clinical Research: Perspectives From Industry

Obstacles for Clinical Research: The BAMI Experience

Regenerative Products In Perspective: Do They Really Work? Are They Enough?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content